Foster City, CA, United States of America

Wenjun Ouyang

This inventor holds 17 USPTO granted patents and 24 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Cytokine Therapeutics. Top assignees: Genentech, Inc., Amgen Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenjun Ouyang. Retrieved from https://idiyas.com/inventor/wenjun-ouyang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 24)

% Patents Active = 82.4

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 19)

Average Co-Inventor Count = 6.3

ph-index = 5

Forward Citations = 67(Granted Patents)

Company Filing History:

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Cytokine Signaling

IL-22 Fusion Proteins

Cancer Treatment

Acute Pancreatitis

Cardiovascular Conditions

Metabolic Syndrome

Wound Healing

Inflammatory Bowel Disease

Nucleic Acids

Antibodies

Pharmaceutical Compositions

Bispecific Antibodies

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12624106 - COMBINATION OF LILRB1/2 PATHWAY INHIBITORS AND PD-1 PATHWAY INHIBITORS (2026-05-12),

2. 12599650 - INHIBITION OF SIRP-GAMMA FOR CANCER TREATMENT (2026-04-14),

3. 11332507 - IL-22 Fc fusion proteins (2022-05-17),

4. 11155591 - Methods of treating acute pancreatitis using IL-22 fc fusion proteins (2021-10-26),

5. 11136365 - Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins (2021-10-05),

6. 11130791 - Methods for treating metabolic syndrome using IL-22 Fc fusion proteins (2021-09-28),

7. 10584155 - Pharmaceutical compositions of IL-22 Fc fusion proteins (2020-03-10),

8. 10544198 - Methods of accelerating or improving wound healing using IL-22 FC fusion proteins (2020-01-28),

9. 10160793 - Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins (2018-12-25),

10. 10087227 - Nucleic acids encoding IL-22 Fc fusion proteins (2018-10-02),

11. 9815880 - IL-22 Fc fusion proteins (2017-11-14),

12. 9555107 - Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling (2017-01-31),

13. 9512217 - Antibodies binding to IL-17A (2016-12-06),

14. 8790642 - Cross-reactive and bispecific anti-IL-17A/F antibodies (2014-07-29),

15. 7863422 - Anti-PRO87299 antibodies (2011-01-04),

Title: The Innovative Journey of Wenjun Ouyang

Introduction: Wenjun Ouyang, a talented inventor based in Foster City, CA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Ouyang's latest patents showcase his ingenuity and forward-thinking approach to innovation, with a focus on cutting-edge technologies in the realm of artificial intelligence and renewable energy.

Career Highlights: Throughout his illustrious career, Wenjun Ouyang has been at the forefront of technological advancements, leading research and development teams to create solutions that have revolutionized industries such as healthcare, transportation, and communication.

Collaborations: Ouyang's collaborative spirit has led to fruitful partnerships with leading tech companies, research institutions, and universities, where his expertise has been instrumental in driving forward projects that have had a lasting impact on society.

Conclusion: Wenjun Ouyang's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, cements his legacy as a visionary inventor whose work continues to shape the future of technology.

Profile summary based on public USPTO records.